EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chronic Activation of Tubulin Tyrosination Improves Heart Function

Niels Pietsch, Christina Y Chen, Svenja Kupsch, Lucas Bacmeister iD, Birgit Geertz, Marisol Herrera-Rivero iD, Bente Siebels iD, Hannah Voß, Elisabeth Krämer, Ingke Braren iD, Dirk Westermann iD, Hartmut Schlüter iD und 7 weitere

Circulation Research · 11.10.2024 · 135 (9) · 910-932

DOI: 10.1161/circresaha.124.324387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 11.10.2024. Verfasst von Niels Pietsch und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pharmacology and Toxicology (N.P., B.G., E.K., G.M., S.S., L.C.), University Medical Center Hamburg-Eppendorf, Hamburg, Ge…. Hauptthemen laut MEDLINE: Tubulin, Myocytes, Cardiac, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common cardiac genetic disorder caused by sarcomeric gene variants and associated with left ventricular hypertrophy and diastolic dysfunction. The role of the microtubule network has recently gained interest with the findings that microtubule detyrosination (dTyr-MT) is markedly elevated in heart failure. Acute reduction of dTyr-MT by inhibition of the detyrosinase (VASH [vasohibin]/SVBP [small VASH-binding protein] complex) or activation of the tyrosinase (TTL [tubulin tyrosine ligase]) markedly improved contractility and reduced stiffness in human failing cardiomyocytes and thus posed a new perspective for HCM treatment. In this study, we tested the impact of chronic tubulin tyrosination in an HCM mouse model ( Mybpc3 knock-in), in human HCM cardiomyocytes, and in SVBP-deficient human engineered heart tissues (EHTs). METHODS: Adeno-associated virus serotype 9–mediated TTL transfer was applied in neonatal wild-type rodents, in 3-week-old knock-in mice, and in HCM human induced pluripotent stem cell–derived cardiomyocytes. RESULTS: We show (1) TTL for 6 weeks dose dependently reduced dTyr-MT and improved contractility without affecting cytosolic calcium transients in wild-type cardiomyocytes; (2) TTL for 12 weeks reduced the abundance of dTyr-MT in the myocardium, improved diastolic filling, compliance, cardiac output, and stroke volume in knock-in mice; (3) TTL for 10 days normalized cell area in HCM human induced pluripotent stem cell–derived cardiomyocytes; (4) TTL overexpression activated transcription of tubulins and other cytoskeleton components but did not significantly impact the proteome in knock-in mice; (5) SVBP-deficient EHTs exhibited reduced dTyr-MT levels, higher force, and faster relaxation than TTL-deficient and wild-type EHTs. RNA sequencing and mass spectrometry analysis revealed distinct enrichment of cardiomyocyte components and pathways in SVBP-deficient versus TTL-deficient EHTs. CONCLUSIONS: This study provides the first proof of concept that chronic activation of tubulin tyrosination in HCM mice and in human EHTs improves heart function and holds promise for targeting the nonsarcomeric cytoskeleton in heart disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TubulinMyocytes, CardiacCardiomyopathy, HypertrophicAnimalsHumansMiceTyrosineMice, Inbred C57BLMice, TransgenicCells, CulturedInduced Pluripotent Stem CellsMaleMyocardial Contraction

Stichwörter der Autor:innen

cardiomyopathy, hypertrophicinduced pluripotent stem cellsmicrotubulesmyocardium

Substanzen

TubulinTyrosine

Autor:innen und Institutionen

  • Department of Experimental Pharmacology and Toxicology (N.P., B.G., E.K., G.M., S.S., L.C.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Germany (N.P., D.W., G.M., S.S., D.L., L.C.).
  • Department of Physiology, Pennsylvania Muscle Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (C.Y.C., M.A.C., B.L.P.).
  • Now with Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (C.Y.C.).
  • Department of Cardiology, University Heart and Vascular Center (S.K., L.B., D.W., D.L.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Now with Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Germany (S.K.).

ORCID-Profile: Lucas Bacmeister, Marisol Herrera-Rivero, Bente Siebels, Ingke Braren, Dirk Westermann, Hartmut Schlüter, Saskia Schlossarek, Jolanda van der Velden, Diana Lindner, Benjamin L Prosser, Lucie Carrier

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Pietsch, N., Chen, C. Y., Kupsch, S., Bacmeister, L., Geertz, B., Herrera-Rivero, M., Siebels, B., Voß, H., Krämer, E., Braren, I., Westermann, D., Schlüter, H., Mearini, G., Schlossarek, S., van der Velden, J., Caporizzo, M. A., Lindner, D., Prosser, B. L., & Carrier, L. (2024). Chronic Activation of Tubulin Tyrosination Improves Heart Function. Circulation Research, 135(9), 910-932. https://doi.org/10.1161/circresaha.124.324387

Vancouver

Pietsch N, Chen CY, Kupsch S, Bacmeister L, Geertz B, Herrera-Rivero M, et al. Chronic Activation of Tubulin Tyrosination Improves Heart Function. Circulation Research. 2024;135(9):910-932. doi:10.1161/circresaha.124.324387

BibTeX
@article{Pietsch2024,
  author = {Pietsch, Niels and Chen, Christina Y and Kupsch, Svenja and Bacmeister, Lucas and Geertz, Birgit and Herrera-Rivero, Marisol and Siebels, Bente and Voß, Hannah and Krämer, Elisabeth and Braren, Ingke and Westermann, Dirk and Schlüter, Hartmut and Mearini, Giulia and Schlossarek, Saskia and van der Velden, Jolanda and Caporizzo, Matthew A and Lindner, Diana and Prosser, Benjamin L and Carrier, Lucie},
  title = {Chronic Activation of Tubulin Tyrosination Improves Heart Function},
  journal = {Circulation Research},
  year = {2024},
  volume = {135},
  number = {9},
  pages = {910--932},
  doi = {10.1161/circresaha.124.324387}
}
Kostenlos starten →